FDA Inspection 1309492 - Naresh P. Singh, MD - March 26, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Naresh P. Singh, MD, with an inspection on March 26, 2026, issued by the San Francisco District Office, covering human drugs.

Company: Naresh P. Singh, MD
Inspection Date: March 26, 2026
Product Type: Human Drugs
Office: San Francisco District Office

Open in Dashboard

ID · 509ee54d-f488-478a-b02b-8106b9d7fb98

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.